Abvc Biopharma (ABVC) Return on Assets [ROA] (2011 - 2026)
Abvc Biopharma (ABVC) reported Return on Assets [ROA] of -38.84% for Q2 2026, down 9.53 percentage points from -29.32% a year earlier but up 5.88 percentage points from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma posted Return on Assets [ROA] of -58.58%, up 10.06 percentage points from FY2024.
- Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +55.74 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -68.64% in FY2024 (+26.74 pp), -95.38% in FY2023 (+44.78 pp), -140.16% in FY2022 (-45.03 pp) and -95.13% in FY2021 (+19.18 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -162.63% in Q4 2022 and a high of -29.23% in Q1 2025.
- Year over year, Return on Assets [ROA] gained in five of the last eight quarters, with an average year-over-year change of +27.96 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2023 (a gain of 94.69 percentage points); the low point was Q4 2022 (a drop of 70.24 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -44.72% (Q1 2026), -39.63% (Q4 2025) and -32.88% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | -38.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.84% |
| Mar 31, 2026 | -44.72% |
| Dec 31, 2025 | -39.63% |
| Sep 30, 2025 | -32.88% |
| Jun 30, 2025 | -29.32% |
| Mar 31, 2025 | -29.23% |
| Dec 31, 2024 | -68.67% |
| Sep 30, 2024 | -65.26% |
| Jun 30, 2024 | -100.42% |
| Mar 31, 2024 | -118.16% |
| Dec 31, 2023 | -67.94% |
| Sep 30, 2023 | -93.25% |
| Jun 30, 2023 | -124.55% |
| Mar 31, 2023 | -119.34% |
| Dec 31, 2022 | -162.63% |
| Sep 30, 2022 | -154.25% |
| Jun 30, 2022 | -130.16% |
| Mar 31, 2022 | -131.41% |
| Dec 31, 2021 | -92.40% |
| Sep 30, 2021 | -94.87% |
API Access
Abvc Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();